Company Offers Service Package To Support Meeting Stringent Industry Standards
Terlux 2802 HD is used to produce a respiratory gas humidifer for intensive-care medicine.
A transparent methacrylate/acrylonitrile/butadiene/styrene (MABS) for external medical and diagnostic equipment applications is now commercially available in North America. BASF (Florham Park, NJ; www.basf.com) launched its Terlux 2802 HD resin in Europe in 2005.
To support customers in meeting the stringent requirements for producing medical and diagnostic equipment, the company offers a comprehensive service package for the resins. As part of the package, BASF agrees to provide advance notice of at least 24 months before any formulation change. Having a constant formulation is essential in the healthcare market, as deviations can require an extensive recertification process.
Other elements of the service package include biocompatibility testing in accordance with United States Pharmacopoeia Class VI and ISO-10933. The package also offers a variety of comprehensive information manufacturers need, such as chemical compatibility, design parameters, and purity specifications.
“Demanding national and international legal requirements have to be met before manufacturers obtain approval for their external medical or diagnostic equipment,” says Tom Hazenstab, product manager for BASF’s Specialty Polymers business in North America.
The transparency and performance attributes of Terlux 2802 HD MABS make the resin suitable for external medical and diagnostic equipment applications. Further benefits include the ability to be gamma sterilized, high impact strength, good chemical resistance, excellent surface quality and luster, and ease of processing.